Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Algernon Pharmaceuticals Inc.
C.AGN
Alternate Symbol(s):
AGNPF
Consumer Cyclical
Healthcare
Advertising Agencies
Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N...
-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:AGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(1122)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jul 06, 2021 10:20am
RE:RE:RE:6 Fold Dilution To Chase After COVID-19. End Of Story.
They have cancelled and walked away from any further work on a Covid-19 therapeutic trial.
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Post by
BlaineBorg
on Jul 06, 2021 9:48am
Worst Case Scenario Now Is Running The Company Into The...
Ground So Kulwant Malhi can come in and do a sub penny takeover. They will do whatever it takes to keep their gravy train moving for insiders. Chris Moreau is a huge disappointment. Ne's
...more
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m
posted Nov 13, 2024 9:00am by
Freegold Ventures Limited
-
|
Four specific holes were drilled to facilitate additional metallurgical testing and were strategically designed to collect representative material from the deposit while improving infill drilling efforts. Approximately ~2,400 meters of ½ PQ core (~ 20 tonnes) have been shipped to BaseMet Labs in Kamloops, BC, where a comprehensive suite of metallurgical testing is currently underway ...read more
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Comment by
BlaineBorg
on Jul 06, 2021 9:38am
RE:RE:6 Fold Dilution To Chase After COVID-19. End Of Story.
Your question makes no sense. You're questioning a clinical trial result that's yet to happen. This isn't back to the future. What's of issue remains the timeline to data. So, if you
...more
(10)
•••
TheWeakendz
X
View Profile
View Bullboard History
Post by
TheWeakendz
on Jul 06, 2021 9:38am
What happened here, wow
Biov, BioVaxy Technology Corp. DD
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Jul 06, 2021 9:24am
RE:6 Fold Dilution To Chase After COVID-19. End Of Story.
I don't mean to question your understanding of the human trial methodology but , hypothetically if you're entire company's life is waiting on a chronic cough trial and the trial
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Jul 06, 2021 9:21am
RE:Shocker - Will Not Advance Ifenprodil into Phase 3
I sincerely hope that a lot of people that were new to the market and did not understand the CSE learnt a lot from this play. This happens all the time and when you call it out , you get called a
...more
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Post by
BlaineBorg
on Jul 06, 2021 9:16am
6 Fold Dilution To Chase After COVID-19. End Of Story.
Without a CEO independent of the board of directors expect more dead end stories and massive dilution to finance all the latest stories lined up. Still no data for IPF and Chronic Cough. It's the
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Jul 06, 2021 8:57am
Shocker - Will Not Advance Ifenprodil into Phase 3
VANCOUVER, British Columbia, July 06, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage
...more
(22)
•••
B52paul
X
View Profile
View Bullboard History
Post by
B52paul
on Jul 05, 2021 5:19pm
Where is the Fda results ??? ALGERNON !!
70 DAYS !
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Comment by
BlaineBorg
on Jul 02, 2021 12:23pm
RE:Management doesn’t respond
Ur wrong AGAIN. They filed on April 23, 2021 - days BEFORE the news release. Your math comes up wrong no matter how you've added it this far. Are you actually looking at a calendar from 2021? BB
(22)
•••
B52paul
X
View Profile
View Bullboard History
Post by
B52paul
on Jul 02, 2021 12:01pm
Management doesn’t respond
JULY 2ND 2021 What are the Bad signs for investors..... ( Algernon Pharmaceuticals Inc) - no updates -no news - no communication -Management doesnt respond.... Algernon Pharmaceuticals files end of
...more
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Post by
BlaineBorg
on Jul 02, 2021 8:36am
70 Day Window for FDA EOP2 Meeting Closed on July 1, 2021.
Christopher Moreau, CEO stated Algernon Pharmaceuticals has "Lot's On The Go". My question for the CEO is how slow is "lot's on the go"? Seems to be more of the same not
...more
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Post by
BlaineBorg
on Jun 30, 2021 8:42am
The CEO Is Getting Torched At InvestorsHub !!!
EOM BB
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Post by
BlaineBorg
on Jun 22, 2021 12:21pm
"Everybody wants in at Phase2" - CEO "500M Market Cap" - CEO
BB
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Post by
BlaineBorg
on Jun 21, 2021 4:29pm
Canadian Government stay handing out money. Will AP Get Any?
Canadian Government To Fund Clinical Trial on Ketamine for Bipolar Disorder The Canadian Institute of Health Research is launching a multi-site clinical trial to study the use of IV Ketamine in
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits